Chronic and Acute Pain Epidemiology Forecast 2025-2034

Acute pain typically lasts a few seconds to three months whereas chronic pain can persist for months or even years. As per a study from the United States Centers for Disease Control and Prevention (CDC), nearly 20.9% of adults in the United States (51.6 million individuals) experienced chronic pain in 2021.

Chronic and Acute Pain Epidemiology Forecast Report Coverage

The “Chronic and Acute Pain Epidemiology Forecast Report 2025-2034” offers comprehensive information on the prevalence and demographics of chronic and acute pain. It projects the future incidence and prevalence rates of chronic and acute pain across various populations. The study covers age and type as major determinants of the chronic and acute pain-affected population. The report highlights patterns in the prevalence of chronic and acute pain over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of chronic and acute pain in the 8 major markets.

Regions Covered

• The United States
• Germany
• France
• Italy
• Spain
• The United Kingdom
• Japan
• India

Chronic and Acute Pain: Disease Overview

Chronic pain generally lasts longer than six months, with pain signals persisting in the nervous system for weeks, months, or even years. Chronic pain can be associated with nerve pain, headache, cancer, arthritis, and fibromyalgia, among others, and causes both physical and emotional effects. On the other hand, acute pain typically doesn’t last longer than six months and is often caused by something specific. It can be caused by broken bones, surgery, burns or cuts, dental work, etc.

Chronic and Acute Pain: Treatment Overview

Over-the-counter drugs or prescription pain relievers can be used for the treatment of acute pain whereas an extensive treatment might be required for addressing chronic pain. Acetaminophen, nonsteroidal anti-inflammatory drugs (NSAIDs), and prescription opioids are common medications for acute pain. For chronic pain, prescription pain relievers, antidepressants, and muscle relaxants are usually taken by the patients. Injection therapies such as epidural steroid injections, trigger point injections, and nerve blocks are also being prescribed for pain relief.

Epidemiology

The chronic and acute pain epidemiology section offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. The publisher provides both current and predicted trends for chronic and acute pain by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for chronic and acute pain and their trends. The data is broken down into specific categories, such as the total diagnosed cases across different age groups and patient pools.

• The rate of chronic pain and high-impact chronic pain (HICP) is estimated to be around 21% and 8% among adults in the United States, respectively, as per a study from the National Institutes of Health.
• The global chronic pain prevalence is around 30% to 40%, according to various regional pain surveys’ estimates.
• According to Saxena, Ashok Kumar et al. (2018), the prevalence of chronic pain in India was reported to be 19.3%, with around 71.2% of sufferers visiting a general practitioner and 4.8% consulting a specialist pain physician.
• Studies show that acute pain is responsible for more than 115 million emergency department visits annually in the United States.

Country-wise Chronic and Acute Pain Epidemiology

The chronic and acute pain epidemiology data and findings for the United States, EU-4 (Germany, Spain, Italy, France), the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of chronic and acute pain varies significantly between countries due to differences in the prevalence of pain-related conditions like arthritis, cancer, or injuries, cultural perception toward pain reporting and management, availability of treatment options, and genetic predispositions, among others. In the United States, nearly 51.6 million individuals, or 20.9% of adults were affected by chronic pain in 2021.

Scope of the Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of chronic and acute pain based on several factors.
• Chronic and Acute Pain Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The report helps to identify the patient population, and the unmet needs of chronic and acute pain are highlighted along with an assessment of the disease's risk and burden.

Key Questions Answered

• What are the key findings of chronic and acute pain epidemiology in the 8 major markets?
• What will be the total number of patients with chronic and acute pain across the 8 major markets during the forecast period?
• What was the country-wise prevalence of chronic and acute pain in the 8 major markets in the historical period?
• Which country will have the highest number of chronic and acute pain patients during the forecast period of 2025-2034?
• Which key factors would influence the shift in the patient population of chronic and acute pain during the forecast period of 2025-2034?
• What are the currently available treatments for chronic and acute pain?
• What are the disease risks, signs, symptoms, and unmet needs of chronic and acute pain?

This product will be delivered within 3-5 business days.